glutamine and a-1331852

glutamine has been researched along with a-1331852 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Zebeeby, A; Alotibi, A; Cohen, GM; Dyer, MJS; Greaves, G; Milani, M; Richards, C; Varadarajan, S; Vogler, M	1

Other Studies

1 other study(ies) available for glutamine and a-1331852

Article	Year
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies. Haematologica, 2019, Volume: 104, Issue:5 Topics: Antineoplastic Agents; bcl-X Protein; Benzothiazoles; Biomimetics; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Glutamine; Humans; Indoles; Isoquinolines; Leukemia, Lymphocytic, Chronic, B-Cell; Lipogenesis; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Cells, Cultured	2019

Article

Year

Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies.

Haematologica, 2019, Volume: 104, Issue:5

Topics: Antineoplastic Agents; bcl-X Protein; Benzothiazoles; Biomimetics; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Glutamine; Humans; Indoles; Isoquinolines; Leukemia, Lymphocytic, Chronic, B-Cell; Lipogenesis; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2019